OTCMKTS:RKAGY RHOEN-KLINIKUM/ADR Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding RHOEN-KLINIKUM/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $10.00 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$10.00Now: $10.00▼$10.0050-Day Range$10.00MA: $10.00▼$10.0052-Week Range$8.52Now: $10.00▼$15.04VolumeN/AAverage Volume1,681 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsHeadlinesShort InterestSocial Media RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2018, it operated 11 hospitals and 5,369 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for RHOEN-KLINIKUM/ADR. Previous Next 2.7 Community Rank Outperform VotesRHOEN-KLINIKUM/ADR has received 60 “outperform” votes. (Add your “outperform” vote.)Underperform VotesRHOEN-KLINIKUM/ADR has received 53 “underperform” votes. (Add your “underperform” vote.)Community SentimentRHOEN-KLINIKUM/ADR has received 53.10% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about RHOEN-KLINIKUM/ADR and other stocks. Vote “Outperform” if you believe RKAGY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RKAGY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldRHOEN-KLINIKUM/ADR does not currently pay a dividend.Dividend GrowthRHOEN-KLINIKUM/ADR does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RHOEN-KLINIKUM/ADR insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medical Care Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RKAGY Previous Symbol CUSIPN/A CIKN/A Webwww.rhoen-klinikum-ag.com Phone49 9771 65 0Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees9,384 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $10.00 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive RKAGY News and Ratings via Email Sign-up to receive the latest news and ratings for RKAGY and its competitors with MarketBeat's FREE daily newsletter. RHOEN-KLINIKUM/ADR (OTCMKTS:RKAGY) Frequently Asked Questions How has RHOEN-KLINIKUM/ADR's stock been impacted by COVID-19? RHOEN-KLINIKUM/ADR's stock was trading at $10.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RKAGY shares have decreased by 0.6% and is now trading at $10.00. View which stocks have been most impacted by COVID-19. Who are some of RHOEN-KLINIKUM/ADR's key competitors? Some companies that are related to RHOEN-KLINIKUM/ADR include Amadeus It Group (AMS), Blvd Centers (CXV), Brain Resource (BRC), Cambian Group (CMBN), CHAMPION PAIN C/SH SH (CPAI), Eviana Health (EHC), Healius (HLS), Konekt (KKT), Medical Facilities (MFCSF), Pacific Smiles Group (PSQ), Premier Health Group (PHGI), Ramsay Health Care Limited Fully Paid Ord. Shrs (RMSYF), SONIC HEALTHCAR/S (SKHHY), Sonic Healthcare (SKHCF) and Sonic Healthcare (SHL). View all competitors. Who are RHOEN-KLINIKUM/ADR's key executives? RHOEN-KLINIKUM/ADR's management team includes the following people: Mr. Stephan Holzinger, Chairman of Board of Management & CEOProf. Bernd Griewing, Chief Medical Officer & Member of Board of ManagementDr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)Julian Schmitt, Head of Investor Relation What is RHOEN-KLINIKUM/ADR's stock symbol? RHOEN-KLINIKUM/ADR trades on the OTCMKTS under the ticker symbol "RKAGY." How do I buy shares of RHOEN-KLINIKUM/ADR? Shares of RKAGY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is RHOEN-KLINIKUM/ADR's stock price today? One share of RKAGY stock can currently be purchased for approximately $10.00. What is RHOEN-KLINIKUM/ADR's official website? The official website for RHOEN-KLINIKUM/ADR is www.rhoen-klinikum-ag.com. How can I contact RHOEN-KLINIKUM/ADR? The company can be reached via phone at 49 9771 65 0. This page was last updated on 9/21/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
